Abstract
We previously reported that a resting heart rate measured at home (home HR) of ≥70 beats per minute was a powerful predictor of the risk of cardiovascular disease mortality, and identified factors affecting home HR in the general Japanese population. The present study examines factors affecting home HR in hypertensive patients treated with antihypertensive medications. Home HR was measured using a home blood pressure (BP) device. Information about the characteristics of the patients was collected using questionnaires administered by a physician. Among 3,400 patients, 3,086 measured home HR both in the morning and evening. The mean values of home HR in the morning and evening were 67.2±9.1 and 69.6±9.2 beats per minute, respectively. Multivariate linear regression analysis showed that lower age, diabetes mellitus, habitual smoking, higher diastolic BP, and the lack of β-blocker or angiotensin-converting enzyme inhibitor use were determinants of elevated morning or evening home HR. These results suggest that adequate control of risk factors for cardiovascular disease such as smoking and diabetes mellitus or use of heart rate–lowering agents might help to decrease home HR in treated hypertensive patients.
Similar content being viewed by others
Article PDF
References
Guidelines Committee : 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
Chobanian AV, Bakris GL, Black HR, et al, National Heart, Lung, and Blood Institute Joint National High Blood Pressure Education Program Coordinating Committee : The seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
Japanese Society of Hypertension : Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29 ( Suppl): S1–S105.
Reims H, Fossum E, Kjeldsen SE, Julius S : Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press 2001; 10: 271–287.
Imai Y, Ohkubo T, Hozawa A, et al: Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19: 179–185.
Ohkubo T, Asayama K, Kikuya M, et al: How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099–1104.
Bobrie G, Chatellier G, Genes N, et al: Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342–1349.
Palatini P, Casiglia E, Julius S, Pessina AC : High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585–592.
Greenland P, Daviglus ML, Dyer AR, et al: Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in industry. Am J Epidemiol 1999; 149: 853–862.
Kristal-Boneh E, Silber H, Harari G, Froom P : The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000; 21: 116–124.
Hozawa A, Ohkubo T, Kikuya M, et al: Prognostic value of home heart rate for cardiovascular mortality in general population. Am J Hypertens 2004; 17: 1005–1010.
Yamaguchi J, Hozawa A, Ohkubo T, et al: Factors affecting home-measured resting heart rate in the general population. Am J Hypertens 2005; 18: 1218–1225.
Ohkubo T, Obara T, Funahashi J, et al: Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004; 27: 755–763.
Obara T, Ohkubo T, Funahashi J, et al: Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens 2005; 23: 1653–1660.
Imai Y, Otsuka K, Kawano Y, et al: Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771–782.
Shirasaki O, Terada H, Niwano K, et al, The Japan Home-Health Apparatus Industrial Association : Investigation of home-use electronic sphygmomanometers. Blood Press Monit 2001; 6: 303–307.
Association for the Advancement of Medical Instrumentation : American National Standard for Electronic or Automated Sphygnomanometers, AAMI Analysis and Review. Washington DC, Association for the Advancement of Medical Instrumentation, 1987.
Imano E, Miyatsuka T, Motomura M, et al: Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria. Diabetes Res Clin Pract 2001; 3: 185–191.
Flanagan DE, Vaile JC, Petley GW, et al: The autonomic control of heart rate and insulin resistance in young adults. J Clin Endocrinol Metab 1999; 4: 1263–1267.
Grassi G, Vailati S, Bertinieri G, et al: Heart rate as marker of sympathetic activity. J Hypertens 1998; 16: 1635–1639.
Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA : Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertnension. Circulation 2003; 108: 3097–3101.
Valensi P : Diabetic autonomic neuropathy: what are the risks? Diabetes Metab 1998; 24 ( Suppl 3): 66–72.
Kawano Y, Abe H, Takishita S, Omae T : Effects of alcohol restriction on 24-hour ambulatory blood pressure in Japanese men with hypertension. Am J Med 1998; 105: 307–311.
Minami J, Ishimitsu T, Matsuoka H : Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999; 33: 586–590.
Carlberg B, Samuelsson O, Lindholm LH : Atenolol in hypertension: is it a wise choice? Lancet 2004; 364: 1684–1689.
Lindholm LH, Carlberg B, Samuelsson O : Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366: 1545–1553.
Bradley HA, Wiysonqe CA, Volmink JA, Mayosi BM, Opie LH : How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 2006; 24: 2131–2141.
NICE/BHS : Clinical guideline 34: hypertension: management of hypertension in adults in primary care: partial update: http://www.nice.org.uk/CG034guidance ( accessed Dec 26, 2006).
Kjekshus JK : Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986; 57: 43F–49F.
Packer M, Bristow MR, Cohn JN, et al, U.S. Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349–1355.
Ligtenberg G, Blankestijn PJ, Oey PL, et al: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321–1328.
Mitchell HC, Pettinger WA, Gianotti L, et al: Further studies on the hypernoradrenergic state of treated hypertensives: effect of captopril. Clin Exp Hypertens A 1983; 5: 1611–1627.
Weinberger MH : Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients. Am J Cardiol 1982; 49: 1542–1543.
Gillman MW, Kannel WB, Belanger A, D'Agostino RB : Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993; 125: 1148–1154.
Benetos A, Rudnichi A, Thomas F, Safar M, Guize L : Influence of heart rate on mortality in French population: role of age, gender and blood pressure. Hypertension 1999; 33: 44–52.
Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A : Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001; 37: 1256–1261.
Palatini P : Need for a revision of the normal limits of resting heart rate. Hypertension 1999; 33: 622–625.
Palatini P, Benetos A, Julius S : Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs 2006; 66: 133–144.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Komai, R., Obara, T., Ohkubo, T. et al. Factors Affecting Heart Rate as Measured at Home among Treated Hypertensive Patients: The Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) Study. Hypertens Res 30, 1051–1057 (2007). https://doi.org/10.1291/hypres.30.1051
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.30.1051
